Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SMALL MOLECULE ACTIVE PHARMACEUTICAL INGREDIENT INDUSTRY
2.1 Summary about Small Molecule Active Pharmaceutical Ingredient Industry
2.2 Small Molecule Active Pharmaceutical Ingredient Market Trends
2.2.1 Small Molecule Active Pharmaceutical Ingredient Production & Consumption Trends
2.2.2 Small Molecule Active Pharmaceutical Ingredient Demand Structure Trends
2.3 Small Molecule Active Pharmaceutical Ingredient Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Standard API
4.2.2 High Potency API
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Cardiovascular Diseases
4.3.2 Respiratory Disorders
4.3.3 Infectious Diseases
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Standard API
5.2.2 High Potency API
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Cardiovascular Diseases
5.3.2 Respiratory Disorders
5.3.3 Infectious Diseases
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Standard API
6.2.2 High Potency API
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Cardiovascular Diseases
6.3.2 Respiratory Disorders
6.3.3 Infectious Diseases
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Standard API
7.2.2 High Potency API
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Cardiovascular Diseases
7.3.2 Respiratory Disorders
7.3.3 Infectious Diseases
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Standard API
8.2.2 High Potency API
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Cardiovascular Diseases
8.3.2 Respiratory Disorders
8.3.3 Infectious Diseases
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Standard API
9.2.2 High Potency API
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Cardiovascular Diseases
9.3.2 Respiratory Disorders
9.3.3 Infectious Diseases
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Johnson Matthey
10.1.2 Siegfried Holding AG
10.1.3 Pfizer
10.1.4 Sanofi S.A.
10.1.5 Novartis AG,
10.1.6 Bristol-Myers Squibb
10.1.7 Boehringer Ingelheim GmbH
10.1.8 GlaxoSmithKline
10.1.9 Albany Molecular Research Inc.
10.1.10 Bachem Holding AG
10.1.11 PCAS
10.1.12 Patheon N.V.
10.1.13 AstraZeneca
10.1.14 Johnson & Johnson
10.1.15 Merck & Co, Inc.
10.1.16 BASF SE
10.1.17 Catalent Inc.
10.1.18 Teva Pharmaceuticals
10.1.19 Roche
10.1.20 Cambrex Corporation
10.1.21 GILEAD Science Inc.
10.2 Small Molecule Active Pharmaceutical Ingredient Sales Date of Major Players (2017-2020e)
10.2.1 Johnson Matthey
10.2.2 Siegfried Holding AG
10.2.3 Pfizer
10.2.4 Sanofi S.A.
10.2.5 Novartis AG,
10.2.6 Bristol-Myers Squibb
10.2.7 Boehringer Ingelheim GmbH
10.2.8 GlaxoSmithKline
10.2.9 Albany Molecular Research Inc.
10.2.10 Bachem Holding AG
10.2.11 PCAS
10.2.12 Patheon N.V.
10.2.13 AstraZeneca
10.2.14 Johnson & Johnson
10.2.15 Merck & Co, Inc.
10.2.16 BASF SE
10.2.17 Catalent Inc.
10.2.18 Teva Pharmaceuticals
10.2.19 Roche
10.2.20 Cambrex Corporation
10.2.21 GILEAD Science Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
1.Table Small Molecule Active Pharmaceutical Ingredient Product Type Overview
2.Table Small Molecule Active Pharmaceutical Ingredient Product Type Market Share List
3.Table Small Molecule Active Pharmaceutical Ingredient Product Type of Major Players
4.Table Brief Introduction of Johnson Matthey
5.Table Brief Introduction of Siegfried Holding AG
6.Table Brief Introduction of Pfizer
7.Table Brief Introduction of Sanofi S.A.
8.Table Brief Introduction of Novartis AG,
9.Table Brief Introduction of Bristol-Myers Squibb
10.Table Brief Introduction of Boehringer Ingelheim GmbH
11.Table Brief Introduction of GlaxoSmithKline
12.Table Brief Introduction of Albany Molecular Research Inc.
13.Table Brief Introduction of Bachem Holding AG
14.Table Brief Introduction of PCAS
15.Table Brief Introduction of Patheon N.V.
16.Table Brief Introduction of AstraZeneca
17.Table Brief Introduction of Johnson & Johnson
18.Table Brief Introduction of Merck & Co, Inc.
19.Table Brief Introduction of BASF SE
20.Table Brief Introduction of Catalent Inc.
21.Table Brief Introduction of Teva Pharmaceuticals
22.Table Brief Introduction of Roche
23.Table Brief Introduction of Cambrex Corporation
24.Table Brief Introduction of GILEAD Science Inc.
25.Table Products & Services of Johnson Matthey
26.Table Products & Services of Siegfried Holding AG
27.Table Products & Services of Pfizer
28.Table Products & Services of Sanofi S.A.
29.Table Products & Services of Novartis AG,
30.Table Products & Services of Bristol-Myers Squibb
31.Table Products & Services of Boehringer Ingelheim GmbH
32.Table Products & Services of GlaxoSmithKline
33.Table Products & Services of Albany Molecular Research Inc.
34.Table Products & Services of Bachem Holding AG
35.Table Products & Services of PCAS
36.Table Products & Services of Patheon N.V.
37.Table Products & Services of AstraZeneca
38.Table Products & Services of Johnson & Johnson
39.Table Products & Services of Merck & Co, Inc.
40.Table Products & Services of BASF SE
41.Table Products & Services of Catalent Inc.
42.Table Products & Services of Teva Pharmaceuticals
43.Table Products & Services of Roche
44.Table Products & Services of Cambrex Corporation
45.Table Products & Services of GILEAD Science Inc.
46.Table Market Distribution of Major Players
47.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
48.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
49.Table Global Small Molecule Active Pharmaceutical Ingredient Market Forecast (Million USD) by Region 2021f-2026f
50.Table Global Small Molecule Active Pharmaceutical Ingredient Market Forecast (Million USD) Share by Region 2021f-2026f
51.Table Global Small Molecule Active Pharmaceutical Ingredient Market Forecast (Million USD) by Demand 2021f-2026f
52.Table Global Small Molecule Active Pharmaceutical Ingredient Market Forecast (Million USD) Share by Demand 2021f-2026f